10x Insights
Loading account…
Companies / Healthcare / InfuSystem Holdings, Inc
INFU

InfuSystem Holdings, Inc

HealthcareSurgical & Medical Instruments
Ticker INFUROCHESTER HILLS, MIFiscal year ends DecemberBook value per share $2.83Diluted shares 20.9M

InfuSystem Holdings, Inc. (NASDAQ: INFN) operates as a leading national healthcare service provider facilitating outpatient care through durable medical equipment solutions and related services. The company's website is www.infusystem.com. From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$143.44M
+6.4% year over year
Last 12 mo $143.33M
8.31%
+3.2 percentage points
Last 12 mo 9.26%
$6.63M
+182.6% year over year
Last 12 mo $8.54M
11.56%
+7.5 percentage points
Last 12 mo 14.44%
Cash & financing
$24.41M
+19.3% year over year
Last 12 mo $23.37M
$15.72M
+498.7% year over year
Last 12 mo $12.55M
0.34
Was 0.41× a year earlier
Last 12 mo 0.35
21.1M
−2.8% year over year
Last 12 mo 20.9M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What InfuSystem Holdings, Inc does

In the company’s own words

InfuSystem Holdings, Inc. (NASDAQ: INFN) operates as a leading national healthcare service provider facilitating outpatient care through durable medical equipment solutions and related services. The company's website is www.infusystem.com.

The company operates through two primary platforms: Patient Services and Device Solutions. The Patient Services segment, which generated approximately 87% of oncology business revenues in 2025, provides turnkey clinic-to-home healthcare solutions centered on electronic ambulatory infusion pumps for chemotherapy delivery. This segment focuses primarily on continuous infusion therapy for colorectal cancer treatment, which represented approximately 43% of Patient Services revenues, while non-colorectal disease states accounted for 44%. The company also offers pain management services through post-operative continuous peripheral nerve block therapy, wound care solutions including negative pressure wound therapy and advanced wound care dressings, and pneumatic compression devices. The Device Solutions segment provides equipment rental and sales, consumable sales, and biomedical support services to oncology practices, hospitals, and other clinical settings.

InfuSystem maintains relationships with approximately 2,100 outpatient oncology clinics and has contracts with nearly 840 third-party payer networks as of December 31, 2025. The company operates from seven locations across the United States and Canada, with a rental fleet of approximately 96 makes and models of equipment. As of December 31, 2025, the company employed 473 full-time and part-time employees.

The company's competitive advantages include its extensive third-party payer network, economies of scale, established relationships with durable medical equipment manufacturers and healthcare providers, large pump fleet enabling rapid delivery, field-based biomedical technicians, and comprehensive repair and service capabilities. InfuSystem has made strategic acquisitions including Apollo Medical Supply in 2025 to expand wound care capabilities, and maintains partnerships such as SI Healthcare Technologies with Sanara MedTech for advanced wound care distribution. The company has developed proprietary information technology solutions including EXPRESS, InfuBus, InfuConnect, DeviceHub, and BlockPain Dashboard to enhance operational efficiency and clinical outcomes.

Company details
Sector
Healthcare
Industry
Surgical & Medical Instruments
Headquarters
ROCHESTER HILLS, MI
Fiscal year end
December
CIK
1337013
SIC
3841

Financial performance, year by year

Fiscal 2013–2025 · USD
$-37.12M$12.12M$61.36M$110.61M$159.85M2013201420152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns InfuSystem Holdings, Inc — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

101
funds hold it
0 of 35
superinvestors hold it
$51.97M
held by funds, at market
27.0%
of shares held by funds

Largest fund holders · InfuSystem Holdings, Inc’s weight in each

Heartland Value Fund
HRTVX · HEARTLAND GROUP INC.
0.58%of fund net assets
First Eagle Small Cap Opportunity Fund
FESRX · First Eagle Funds
0.29%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
Avantis U.S. Small Cap Value ETF
AVUV · American Century ETF Trust
0.02%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.01%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do InfuSystem Holdings, Inc and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of InfuSystem Holdings, Inc's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in InfuSystem Holdings, Inc's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.